CapitalBio Technology logo — Stick to Technological Innovation, Build The Dream of Health...

CapitalBio Technology

Stick to Technological Innovation, Build The Dream of Health

Founded 2012 China Beijing, China 5 employees Private Equity Total: $833.00M Biotechnology, Health Care +2

General Information

Company Name CapitalBio Technology
Founded Year 2012
Location China Beijing, China
Employees 5
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with CapitalBio Technology. To contact CapitalBio Technology, visit capitalbiotechnology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CapitalBio Technology

CapitalBio Technology is an industrial platform under CapitalBio Corporation and National Engineering Research Center for Beijing Biochip Technology. Established in 2012, the company has positioned itself as a key player in the biotechnology and healthcare industries, with a strong focus on technological innovation. With a presence in key cities including Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong, and Santiago, US, and a workforce of over 2,000 employees, CapitalBio Technology has a total office area of more than 150,000 m2. The Company received Private Equity Round investment on 01 January 2021 from Junci Investment, reaffirming investor confidence in its potential for growth and success. CapitalBio Technology's dedication to technological innovation and the dream of health positions it as a promising venture in the rapidly evolving biotechnology and healthcare sectors.

Taxonomy: Life Sciences, Healthcare Solutions, Biochips, Microarray, Microfluidic Chips, Instrumentation, Research and Development, Clinical Diagnostics, Drug Development, Biosafety, Food Safety, Molecular Breeding, Biomedical Research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 2
New Alliance Capital, Junci Investment
01 Jan 2021
Series C CNY800.00M 8
TUS-Holdings, 北京新鼎荣盛资本管理有限公司 +6
29 Jun 2020
Series B CNY20.00M -
18 Dec 2017
Series A CNY10.00M -
07 Jun 2016
Angel Round CNY3.00M -
17 Aug 2012

CapitalBio Technology Alternatives & Competitors

View All Alternatives
CapitalBio Technology vs
InDevR, Inc.
InDevR, Inc. United States

InDevR is a global leader in progressive new analytical technologies for vaccines and other biothera...

Series B
25 employees
Biotechnology, Health Care
CapitalBio Technology vs
Correlia Biosystems
Correlia Biosystems United States

Next-gen instruments for quantitative protein measurement (We are hiring, check indeed for positions...

Venture round
11 employees
Biotechnology, Health Care
CapitalBio Technology vs

Episozyme

1 employees
Biotechnology, Life Sciences

FAQ About CapitalBio Technology

Stick to Technological Innovation, Build The Dream of Health
CapitalBio Technology was founded in 2012.
CapitalBio Technology is headquartered in Beijing, China.
CapitalBio Technology operates in Biotechnology, Health Care, Life Sciences and AgriTech. Its work centres on Life Sciences, Healthcare Solutions, Biochips and Microarray.
CapitalBio Technology has approximately 5 employees.
CapitalBio Technology has completed 5 funding rounds, raising a total of $833.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to CapitalBio Technology include InDevR, Inc., Correlia Biosystems, KTK BIOTECH , Arrayit, EOLO PHARMA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CapitalBio Technology and InDevR, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CapitalBio Technology, https://bouncewatch.com/company/capitalbio-technology, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes